NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2 receptors—implications for models of schizophrenia-Reference-Cited by-同舟云学术

NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2 receptors—implications for models of schizophrenia

Published:2002-09 Issue:8 Volume:7 Page:837-844
ISSN:1359-4184
Container-title:Molecular Psychiatry
language:en
Short-container-title:Mol Psychiatry

Author:

Kapur S,Seeman P

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology

Link

http://www.nature.com/articles/4001093.pdf

Reference59 articles.

1. Laruelle M, Abi-Dargham A . Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies J Psychopharmacol 1999; 13: 358–371

2. Seeman P, Kapur S . Schizophrenia: more dopamine, more D2 receptors Proc Natl Acad Sci U S A 2000; 97: 7673–7675

3. Kapur S, Seeman P . Does fast dissociation from the dopamine D2 receptors explain atypical antipsychotic action—a new hypothesis Am J Psychiatry 2001; 158: 360–369

4. Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmuller B . Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia Neurosci Lett 1980; 20: 379–382

5. Carlsson M, Carlsson A . Interactions between glutamatergic and monoaminergic systems within the basal ganglia—implications for schizophrenia and Parkinson's disease Trends Neurosci 1990; 13: 272–276

Cited by 385 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aberrant glutamatergic systems underlying impulsive behaviors: Insights from clinical and preclinical research;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-12

2. Benefits and risks of esketamine nasal spray continuation in treatment-resistant depression;Biomarkers in Neuropsychiatry;2024-12

3. Is the antidepressant effect of ketamine separate from its psychotomimetic effect? A review of rodent models;Neuropharmacology;2024-11

4. The Dopaminergic Effects of Esketamine are Mediated by a Dual Mechanism Involving Glutamate and Opioid Receptors;2024-07-22

5. The N -methyl- d -aspartate receptor hypothesis of ketamine’s antidepressant action: evidence and controversies;Philosophical Transactions of the Royal Society B: Biological Sciences;2024-06-10